Related references
Note: Only part of the references are listed.Non-invasive diagnosis of hepatocellular carcinoma revisited
Cora Mueller et al.
GUT (2018)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study
Nicolas Pote et al.
LIVER INTERNATIONAL (2018)
Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification
Julien Calderaro et al.
JOURNAL OF HEPATOLOGY (2017)
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
Martina Schmittnaegel et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Acute tumour response to a bispecific Ang-2-VEGF-A antibody: insights from multiparametric MRI and gene expression profiling
Lauren C. J. Baker et al.
BRITISH JOURNAL OF CANCER (2016)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2
Florence T. H. Wu et al.
EMBO MOLECULAR MEDICINE (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Biopsy for Liver Cancer: How to Balance Research Needs With Evidence-Based Clinical Practice
Morris Sherman et al.
HEPATOLOGY (2015)
Liver Cancer Biopsy - Back to the Future?!
Michael Torbenson et al.
HEPATOLOGY (2015)
A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner
Jian-Hong Fang et al.
HEPATOLOGY (2015)
Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas
Antonio Solinas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Telomerase Reverse Transcriptase Promoter Mutation Is an Early Somatic Genetic Alteration in the Transformation of Premalignant Nodules in Hepatocellular Carcinoma on Cirrhosis
Jean Charles Nault et al.
HEPATOLOGY (2014)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki et al.
NATURE GENETICS (2014)
Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
Damien Gerald et al.
CANCER RESEARCH (2013)
High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions
Jean Charles Nault et al.
NATURE COMMUNICATIONS (2013)
A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition
Jae Yeon Seok et al.
HEPATOLOGY (2012)
Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell-Cell Junctions and Lung Metastasis
Tanja Holopainen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Liver Transplantation for Advanced Hepatocellular Carcinoma Using Poor Tumor Differentiation on Biopsy as an Exclusion Criterion
Derek DuBay et al.
ANNALS OF SURGERY (2011)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Human Hepatocellular Carcinomas With Stemness-Related Marker Expression: Keratin 19 Expression and a Poor Prognosis
Haeryoung Kim et al.
HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
Hiroya Hashizume et al.
CANCER RESEARCH (2010)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
Pulmonary Vascular Destabilization in the Premetastatic Phase Facilitates Lung Metastasis
Yujie Huang et al.
CANCER RESEARCH (2009)
Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets
Sandrine Boyault et al.
HEPATOLOGY (2007)
Share Paper
